Close this search box.
Subscriber Log In

Biotech Investment in 2022 : “You’ve Got to Kiss a Lot of Frogs”

kiss frogs

The market may be tough, but with unprecedented innovation taking place, there’s plenty for biotechs and investors to feel positive about in the long term. You may (or indeed may not) have seen our recent webinar, Tricky Terrain: Navigating the pharma investment landscape. If you did miss it, check it out to get a quick […]